CIK 0001781174
- Emerging growth company
Acrivon Therapeutics, Inc.
Sign in to watch- Ticker
- ACRV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 825125532
- Phone
- +1 617-207-8979
- Business address
- 480 ARSENAL WAY, SUITE 100, WATERTOWN, MA, 02472
- 4 Shares withheld for taxes Chief Legal Officer gave up 652 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Legal Officer gave up 735 shares (to pay taxes)
- 4 Shares withheld for taxes EVP - Business Operations gave up 1,900 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,470 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 1,395 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 2,450 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 239,023 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 2,232 shares (to pay taxes)
- 4 Grant or award Chief Legal Officer acquired 3,858 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award President and CEO acquired 493,994 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 16 shares at $12.93 ($207)
- 4 Exercise or conversion Chief Financial Officer acquired 9,500 shares (option exercise)
- 4 Open-market sale 10% owner sold 2,056 shares at $12.14 ($24,960)
- 4 Open-market sale 10% owner sold 5,893 shares at an average $12.29 ($72,412)
- 4 Exercise or conversion Chief Operating Officer acquired 9,225 shares (option exercise)
Page 9 of 11 · 206 filings